Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: ExtraBases who wrote (27374)	2/2/1999 11:14:00 PM
From: Karl Drobnic	Read Replies (2) \| Respond to of 31646

Thanks for the CMED post. I'm guessing that TAVA will recognize 1/2 the $300,000 in BioMedY2k revenues. Also, the $300,000 should have generated some hits to the database, which I assume would be all TAVA money (again, I'm guessing). So with a little stretching, I'll guess BioMedY2k adds $.01 to Tava's EPS. Friday, JJ used the word "screaming" to describe the growth in Tava/Beck, so maybe $.03 coming in from there. I'm pretty comfortable with $.25/share EPS for Dec. 31. quarter.